dilatrend carvedilol 12.5mg tablet blister pack
pharmaco australia ltd - carvedilol, quantity: 12.5 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; sucrose; magnesium stearate; colloidal anhydrous silica; povidone; crospovidone; iron oxide yellow; iron oxide red - dilatrend is indicated for the treatment of mild to moderate hypertension. data have not been provided to support the use of this drug in severe hypertension or renovascular disease. dilatrend is indicated for the treatment of patients with symptomatic mild to moderate (nyha class ii & iii) congestive heart failure, as an adjunct to conventional treatments (e.g diuretics, digoxin, ace inhibitors and vasodilators). indications as at 24 january 2002: dilatrend is indicated for the treatment of mild to moderate hypertension. data have not been provided to support the use of this drug in severe hypertension or renovascular disease. dilatrend is indicated for the treatment of patients with symptomatic mild to severe (nyha class ii - iv) congestive heart failure (chf) as an adjunct to conventional treatments (e.g. diuretics, digoxin, ace inhibitors and vasodilators). indications as at 3 march 2003: dilatrend is indicated for the treatment of hypertension. data have not been provided to support the use of this drug in renovascular disease. dilatrend is indicated for the treatment of patients with symptomatic mild to severe (nyha class ii - iv) congestive heart failure (chf) as an adjunct to conventional treatments (e.g. diuretics, digoxin, ace inhibitors and vasodilators).
dilatrend carvedilol 6.25mg tablet blister pack
pharmaco australia ltd - carvedilol, quantity: 6.25 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; sucrose; magnesium stearate; colloidal anhydrous silica; povidone; crospovidone; iron oxide yellow - dilatrend is indicated for the treatment of mild to moderate hypertension. data have not been provided to support the use of this drug in severe hypertension or renovascular disease. dilatrend is indicated for the treatment of patients with symptomatic mild to moderate (nyha class ii & iii) congestive heart failure, as an adjunct to conventional treatments (e.g diuretics, digoxin, ace inhibitors and vasodilators). indications as at 24 january 2002: dilatrend is indicated for the treatment of mild to moderate hypertension. data have not been provided to support the use of this drug in severe hypertension or renovascular disease. dilatrend is indicated for the treatment of patients with symptomatic mild to severe (nyha class ii - iv) congestive heart failure (chf) as an adjunct to conventional treatments (e.g. diuretics, digoxin, ace inhibitors and vasodilators). indications as at 3 march 2003: dilatrend is indicated for the treatment of hypertension. data have not been provided to support the use of this drug in renovascular disease. dilatrend is indicated for the treatment of patients with symptomatic mild to severe (nyha class ii - iv) congestive heart failure (chf) as an adjunct to conventional treatments (e.g. diuretics, digoxin, ace inhibitors and vasodilators).
dilatrend 12,5 mg comprimés
cps cito pharma services gmbh - carvedilolum - comprimés - carvedilolum 12.5 mg, saccharum 12.5 mg, lactosum monohydricum 59.1 mg, povidonum k 25, silica colloidalis anhydrica, crospovidonum, magnesii stearas, e 172 (flavum), e 172 (rubrum), pro compresso. - l'alpha et le bêta-bloquants - synthetika
dilatrend 25 mg comprimés
cps cito pharma services gmbh - carvedilolum - comprimés - carvedilolum 25 mg, saccharum 25 mg, lactosum monohydricum 10 mg, povidonum k 25, silica colloidalis anhydrica, crospovidonum, magnesii stearas, pro compresso. - l'alpha et le bêta-bloquants - synthetika
dilatrend 6,25 mg comprimés
cps cito pharma services gmbh - carvedilolum - comprimés - carvedilolum 6.25 mg, saccharum 21.25 mg, lactosum monohydricum 51.8 mg, povidonum k 25, silica colloidalis anhydrica, crospovidonum, magnesii stearas, e 172 (flavum), pro compresso. - l'alpha et le bêta-bloquants - synthetika
dilatrend
roche products pty ltd - carvedilol -
dilatrend
pharmaco (nz) ltd - carvedilol 12.5mg - tablet - 12.5 mg - active: carvedilol 12.5mg excipient: colloidal silicon dioxide crospovidone iron oxide red iron oxide yellow lactose monohydrate magnesium stearate povidone sucrose - indicated for the management of essential hypertension. it can be used alone or in combination with other antihypertensive agents (e.g. calcium channel blockers, diuretics).
dilatrend
pharmaco (nz) ltd - carvedilol 25mg - tablet - 25 mg - active: carvedilol 25mg excipient: colloidal silicon dioxide crospovidone lactose monohydrate magnesium stearate povidone sucrose - indicated for the management of essential hypertension. it can be used alone or in combination with other antihypertensive agents (e.g. calcium channel blockers, diuretics).
dilatrend
pharmaco (nz) ltd - carvedilol 6.25mg - tablet - 6.25 mg - active: carvedilol 6.25mg excipient: colloidal silicon dioxide crospovidone iron oxide yellow lactose monohydrate magnesium stearate povidone sucrose - indicated for the management of essential hypertension. it can be used alone or in combination with other antihypertensive agents (e.g. calcium channel blockers, diuretics).
dilatrend 25 mg 30 tablet
deva - karvedilol - allegra